Abstract
The movement of calcium ions across cellular membranes (e. g., plasma membrane, endoplasmic or sarcoplasmic reticulum) can serve as a molecular messenger that modulates biochemical processes appropriate to the specific cell type. Calcium antagonists by preventing release of Ca2+ from intracellular stores, by peventing influx of external Ca2+ or by inhibiting the effects of Ca2+ through interactions with Ca2+-binding proteins such as calmodulin can interfere with these biochemical functions. The primary action of one subgroup of calcium antagonists is to interact with the channels in the cell membrane through which calcium enters the cells. This class of compounds originally described by Fleckenstein has been called by a variety of names including Ca2+-channel blockers, Ca2+-entry blockers, Ca2+-channel inhibitors and slow-channel blockers (for review see 1–3). We will use the terminology calcium channel blockers (CCB) in this chapter.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Fleckenstein A. Annu. Rev. Pharmacol. Toxicol. 17: 149–166, 1977.
Janis RA and Triggle RJ. J. Med. Chem. 26: 775–785, 1983.
Braunwald E. N. Engl. J. Med. 307: 1618–1627, 1982.
Murphy KMM, Gould RJ, Largent BL and Snyder SH. Proc. Natl. Acad. Sci. USA 80: 860–864, 1983.
Nayler WS and Grinwald P. Fed. Proc. Fed. Am. Soc. Exp. Biol. 40: 2855–2861, 1981.
Lee KS and Tsien RW. Nature (London) 302: 790–794, 1983.
Janis RA and Scriabine A. Biochem. Pharmacol. 32: 3499–3507, 1983.
Wellens D, Goossens T and Reyntjens A. Angiology 12: 821–827, 1980.
Conti CR. J. Fl. Med. Assoc. 68: 883–886, 1981.
Murphy KMM and Synder SH. Eur. J. Pharmacol. 77: 201–202, 1982.
Motulsky HJ, Snavely MD, Hughes RJ and Insel PA. Circ. Res. 52: 226–231, 1983.
Tsuruo T, Iida H, Tsukagoshi S and Sakurai Y. Cancer Res. 43: 2267–2272, 1983.
Tsuruo T, Iida H, Nojiri M, Tsukagoshi S and Sakurai Y. Cancer Res. 43: 2905–2910, 1983.
Kaelin WG, Shrivastav S, Shand DG and Jirtle RL. Cancer Res. 42: 3944–3949, 1982.
Winquist RJ, Webb RC and Bohr DF. Fed. Proc. Fed. Am. Soc. Exp. Biol. 40: 2852–2854, 1981.
Honn KV, Menter DG, Onoda JM, Taylor JD and Sloane BF. In: Cancer Invasion and Metastasis (Eds. Nicolson GL and Milas L), Raven Press: New York, pp. 361–388, 1984.
Bastida E, Ordinas A and Jamieson GA. Nature (London) 291: 661–662, 1981.
Hara Y, Steiner M and Baldini MS. Cancer Res. 40: 1217–1222, 1980.
Karpatkin S, Smerling A and Pearlstein E. J. Lab. Clin. Med. 96: 994–1001, 1980.
Gasic GJ, Gasic TB and Stewart CC. Proc. Natl. Acad. Sci. USA 61: 46–52, 1968.
Gastpar H, Ambrus J and Thurber LE. J. Med. 8: 53–56, 1977.
Gasic GJ, Gasic TB, Galanti N, Johnson T and Murphy J. Int. J. Cancer 11: 704–718, 1973.
Honn KV, Busse WD and Sloane BF. Biochem. Pharmacol. 32: 1–11, 1983.
Menter DG, Onoda JM, Taylor JD and Honn KV. Cancer Res. 44: 450–456, 1984.
Lerner WA, Pearlstein E, Ambrogio C and Karpatkin S. Int. J. Cancer 31: 463–469, 1983.
Honn KV. Clin. Exp. Metastasis 1: 103–114, 1983.
Honn KV, Cicone B and Skoff A. Science 212: 1270–1272, 1981.
Owen NE, Feinberg H and Lebreton GC. Am. J. Physiol. 239: H483–H488, 1980.
Owen NE and Lebreton GC. Am. J. Physiol. 241: H613–H619, 1981.
Miller OV, Johnson RA and Gorman RR. Prostaglandins 13: 599–609, 1977.
Gorman RR. Fed. Proc. Fed. Am. Soc. Exp. Biol. 38: 83–88, 1979.
Fleckenstein A. Arzneim.Forsch./Drug Res. 20: 1317–1322, 1970.
Godfraind T. Fed. Proc. Fed. Am. Soc. Exp. Biol. 40: 2866–2871, 1981.
Ono H and Kimura M. Arzneim.Forsch./Drug Res. 31: 1131–1134, 1981.
Schmunk GA and Lefer AM. Res. Commun. Chem. Pathol. Pharmacol. 35: 179–187, 1982.
Ribeiro LGT, Brandon TA, Horak JK, Ware JA, Miller RR and Solis RT. J. Cardiovas. Pharmacol. 4: 170–173, 1982.
Han P, Boatwright C and Ardlie NG. Thromb. Haemostas. 50: 513–517, 1983.
Dale J, Landmark KH and Myhre E. Am. Heart J. 105: 103–105, 1983.
Shinjo A, Sasaki Y, Inamasu M and Morita T. Thromb. Res. 13: 941–955, 1978.
Okamatsu S, Peck RC and Lefer AM. Proc. Soc. Exp. Biol. Med. 166: 551–555, 1981.
Ikeda Y, Kikuchi M, Toyama K, Wantanabe K and Ando Y. Thromb. Haemostasis 45: 158–161, 1981.
Addonizio VP, Fisher CA, Strauss JF and Edmunds LH. Thromb. Res. 28: 545–556, 1982.
Mehta J, Mehta P, Ostrowski N and Crews F. Thromb. Res. 30: 469–475, 1983.
Maclntyre DE and Shaw AM. Thromb. Res. 21: 833–844, 1983.
Mehta P, tfehta J, Ostrowski N and Brigmon L. J. Lab. Clin. Med. 102: 332–339, 1983.
Schomerus M, Spiegelhalder B, Stevens B and Eichelbaum K. Cardiovas. Res. 10: 605–612, 1976.
Foster TS, Hamann SR, Richards VR, Bryant PJ, Graves DA and McAllister RG. J. Clin. Pharmacol. 23: 161–170, 1983.
Rybicki JP and LeBreton GC. Thromb. Res. 30: 407–414, 1983.
Onoda JM, Sloane BF and Honn KV. Submitted.
Honn KV, Onoda JM, Diglio CA, Carufel MM, Taylor JD and Sloane BF. Clin. Exp. Metastasis, in press.
Honn KV, Onoda JM, Diglio CA and Sloane BF. Proc. Soc. Exp. Biol. Med. 174: 16–19, 1983.
Honn KV, Onoda JM, Pampalona K, Battaglia M, Neagos G, Taylor JD, Diglio CA and Sloane BF. Submitted.
Gerold M, Eigenmann R and Haeusler G. J. Cardiovas. Pharmacol. 4: 419–429, 1982.
Norman JA, Ansell J and Phillips MA. Eur. J. Pharmacol. 93: 107–112, 1983.
Bostrum SL, Ljung B, Mardh S, Forsen S and Thulin E. Nature (London) 292: 777–778, 1981.
Srivastava KC and Awasthi KK. Prostaglandins Leukotrienes Med. 10: 411–417, 1983.
Maniglia CA, Tudor G, Gomez J and Sartorelli AC. Cancer Lett. 16: 253–260, 1982.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Martinus Nijhoff Publishing, Boston
About this chapter
Cite this chapter
Onoda, J.M., Sloane, B.F., Taylor, J.D., Honn, K.V. (1984). Calcium Channel Blockers: Inhibitors of Tumor Cell-Platelet-Endothelial Cell Interactions. In: Honn, K.V., Sloane, B.F. (eds) Hemostatic Mechanisms and Metastasis. Developments in Oncology, vol 22. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-3831-4_16
Download citation
DOI: https://doi.org/10.1007/978-1-4613-3831-4_16
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-3833-8
Online ISBN: 978-1-4613-3831-4
eBook Packages: Springer Book Archive